Drotaverine PCD Pharma Franchise Company
Cafoli Lifecare offers a strong Drotaverine PCD pharma franchise spanning 9 formulations across tablets, injection and suspension, all made at WHO-GMP certified plants. This gives franchise partners a versatile antispasmodic line for physicians, gynaecologists and gastroenterologists.
What is Drotaverine?
Drotaverine is a smooth-muscle antispasmodic that works by selective inhibition of phosphodiesterase-4 (PDE4), relaxing smooth muscle without the anticholinergic side effects of older agents. It is widely used to relieve spasmodic pain in the gastrointestinal, biliary, urinary and gynaecological tracts. Read its profile on PubChem.
Therapeutic Applications
Drotaverine is prescribed for renal and biliary colic, irritable bowel and other GI spasms, dysmenorrhoea, and to ease cervical dilatation during labour. Its tablet, injection and paediatric suspension forms cover outpatient, emergency and obstetric use. Prescribers include general physicians, gynaecologists, gastroenterologists and urologists.
Why Drotaverine is a High-Potential Molecule for Distributors
Antispasmodics have broad, cross-specialty and acute-care demand — colicky pain presents in emergency, gynaecology and GI clinics alike. Drotaverine's cleaner side-effect profile versus anticholinergic antispasmodics keeps it a preferred first choice, and its use in labour analgesia adds an obstetric channel. Multiple dosage forms from one molecule let a distributor serve many prescriber types with a single SKU family.
Why Choose Cafoli Lifecare
Cafoli Lifecare provides territory-wise monopoly rights, WHO-GMP certified manufacturing, DCGI-approved formulations, complete promotional inputs and the backing of 1000+ franchise partners across India.
References
- PubChem: Drotaverine
- PubMed: Drotaverine literature
Our formulations of Drotaverine find application in many critical therapeutic areas. Its therapeutic spectrum includes, but is not limited to: